Advisor of Innovation Program
Dr. Hailing Yang is a senior analyst at Decision Resources Group, a healthcare information company, where he focuses on market dynamics and opportunities of several major autoimmune diseases, including rheumatoid arthritis, spondyloarthritis, and psoriasis, and topics ranging from biosimilars to healthcare big data. He is actively engaged with the top US/EU rheumatologists and dermatologists has published over twenty primary market research reports and has assisted numerous pharmaceutical/biotech companies in navigating the ever-changing disease landscapes.
Dr. Yang earned a BS in Biology from Wuhan University, China and a Ph.D. in Cellular and Molecular Physiology from Tufts University, where he conducted translational research on cancer invasion and cancer stem cells in glioblastoma, the most lethal form of brain cancer, and contributed to two papers published in Cell.
Dr. Yang serves as president and board member of Wuhan University Alumni Association at Boston. He has also contributed to organizing multiple events of U.S.-China Health Summit since 2015 and serves as the advisor for biotechnology.